Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology reports developments in digital orthodontics and restorative dentistry through its Invisalign System of clear aligners, iTero intraoral scanners, exocad CAD/CAM software and the Align Digital Platform. Company news commonly covers product and workflow updates for clear-aligner treatment planning, intraoral scanning, 3D visualization and digitally connected dental practices.
Recurring updates also include quarterly and annual operating results, clear-aligner shipment and channel trends, regional demand, foreign-exchange effects, stock repurchase activity, financial-conference participation and governance or shareholder-voting matters. Other announcements describe clinical education, professional collaborations and access-to-care initiatives involving orthodontists, general practitioner dentists and dental research organizations.
Align Technology (NASDAQ: ALGN) highlighted its Align Digital Platform innovations at the Greater New York Dental Meeting 2025 on December 3, 2025, showcasing hardware, software, and clinical education for dental professionals.
Key demos included the iTero Lumina scanner with Multi-Direct Capture and larger field of view, Invisalign Smile Architect with Multiple Treatment Plans, ClinCheck Signature global rollout, iTero Design Suite for in-practice 3D printing, Align Oral Health Suite, and exocad DentalCAD 3.3 Chemnitz with upgraded Implant Module and AI-enabled multi-unit design.
Align Technology (Nasdaq: ALGN) was named Most Honored Company in Extel Insights' 2025 All-America Executive Team rankings and earned multiple #1, #3 and top-10 placements across leadership, board, investor relations, and investor/analyst event categories.
Key recognitions included Best CEO Joseph Hogan (#1 Large-Cap, #3 sector), Best CFO John Morici (#1 Large-Cap, #3 sector), Best Company Board (#1 Large-Cap), and top rankings for the IR program, IR team, IR professionals, and investor/analyst event. The awards mark Align's third Extel recognition in four years.
Align Technology (Nasdaq: ALGN) announced commercial availability on November 25, 2025 of the Invisalign System with mandibular advancement featuring occlusal blocks for growing patients.
The product targets ages 10–16, combines mandibular advancement with tooth alignment in one appliance, uses solid laser‑welded occlusal blocks and SmartTrack™ material for durability and comfort, and enables earlier mandibular advancement in deep‑bite Class II cases. Initial commercial rollout covers multiple APAC markets including the Philippines, Australia, Japan, China, India and others.
Align Technology (Nasdaq: ALGN) will present at four upcoming financial conferences in November–December 2025: UBS Global Healthcare (Nov 11), Jefferies Healthcare (Nov 18), Piper Sandler Healthcare (Dec 2), and Evercore Healthcare (Dec 3). Senior executives scheduled to speak include Joe Hogan (President & CEO), John Morici (EVP Global Finance and CFO), and other senior finance and investor relations leaders.
All presentations will be webcast live via the Investor Relations site at http://investor.aligntech.com, with archived replays available on the site for approximately one month.
Align Technology (NASDAQ: ALGN) opened its 2026 Annual Research Award Program offering up to $300,000 in total funding to support clinical and scientific dental research at universities worldwide. Individual regional awards include four one-year grants up to $25,000 each for Americas, EMEA, and APAC. The program has funded approximately $3.96 million since 2010. Applications are due by 5:00 p.m. PT on March 6, 2026, and awardees will be notified by June 1, 2026.
Eligible applicants are university faculty where Invisalign or iTero is available; selections follow independent academic review and Align’s final decision.
Summary not available.
Align Technology (NASDAQ: ALGN) announced a suite of iTero Digital Solutions innovations on October 29, 2025 that expand chairside visualization, design and production workflows to boost patient engagement and treatment conversion.
Key features include the Align Oral Health Suite, Patient Gallery, simplified Oral Health Reports with QR sharing, Invisalign Outcome Simulator Pro with Smile Video (claimed to double chairside conversion for general dentistry), expanded iTero Design Suite compatibility with many 3D printers and mills, a new mock-up workflow for single-visit dentistry, and premium training and support.
New tools are globally available subject to regional regulatory approvals; Invisalign Outcome Simulator Pro availability is limited to iTero Element Plus Series and the company cites >115,000 simulations to date.
Align Technology (NASDAQ: ALGN) announced ClinCheck Live Plan, a new ClinCheck feature that automates initial Invisalign treatment plans and returns a doctor-ready 3D plan in about 15 minutes. Built on Align’s proprietary data and algorithms and experience from >21 million Invisalign patients, the system applies a doctor’s pre-configured preferences and runs quality checks after a Flex Rx submission and iTero scan. Align says ClinCheck Live Plan can shorten planning from days to minutes, enable in‑office plan approval, and improve office efficiency and patient experience. Global roll‑out is planned to begin in Q1 2026 with training resources provided.
Align Technology (NASDAQ: ALGN), a global leader in digital orthodontics and restorative dentistry, will release its Q3 2025 financial results on Wednesday, October 29, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results.
Align Technology is known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company serves over 286,400 doctors globally and has treated more than 20.8 million patients with the Invisalign System over 28 years, targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ:ALGN) hosted its 2025 Global Faculty Meeting, bringing together over 100 Invisalign® and iTero™-trained doctor educators for comprehensive education workshops. The event, themed "Innovate. Collaborate. Educate.," focused on Align's latest innovations, clinical evidence, and best practices for treating patients of all ages.
Key highlights include the launch of a new clinical evidence webpage featuring 800+ peer-reviewed publications, expansion of the Align Global Gallery™ to over 1,500 case studies, and the continuation of the research awards program, which has provided $4 million in grants since 2010. The meeting featured presentations on patient demand, practice growth, clinical insights, and case discussions, reinforcing Align's commitment to advancing digital orthodontics and dentistry.